Planet 13 Holdings (PLNH) Capital Expenditures Growth (1y) (2022 - 2026)
Planet 13 Holdings (PLNH) Capital Expenditures Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.95 Bn | 88.09 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.88 Bn | 32.14 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.04 Bn | 20.88 Bn | 648.10 Mn | 32.98% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.37 Bn | 18.57 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.45 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | -21.54% |
| 10 | Planet 13 Holdings | 39.32 Mn | 23.06 Mn | 9.41 Mn | -75.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -75.28% |
| Dec 31, 2025 | -70.51% |
| Sep 30, 2025 | -65.54% |
| Jun 30, 2025 | -44.09% |
| Mar 31, 2025 | -8.68% |
| Dec 31, 2024 | 9.04% |
| Sep 30, 2024 | 24.87% |
| Jun 30, 2024 | 875.57% |
| Mar 31, 2024 | -19.33% |
| Dec 31, 2023 | 15.64% |
| Sep 30, 2023 | -32.09% |
| Jun 30, 2023 | -94.59% |
| Mar 31, 2023 | -9.27% |
| Dec 31, 2022 | -82.09% |
| Sep 30, 2022 | -5.50% |
| Jun 30, 2022 | -3.79% |
| Mar 31, 2022 | 15.98% |